About Symbollon Pharmaceuticals, Inc. (Otcbb: SYMBA) is a specialty pharmaceutical company focused on the development and commercialization of proprietary products based on its molecular iodine technology for women's healthcare and antimicrobials uses. For more information about Symbollon, please visit the company's website at http://www.symbollon.com.
Fact Sheet (Click below for more Information / PDF Documents)
[AP] - Oil prices rose to near $75 a barrel Thursday in Asia after a report showed U.S. crude inventories fell more than expected, suggesting demand may be improving.
[AP] - Britain's financial regulator hit Goldman Sachs International with a 17.5 million pounds fine on Thursday for failing to notify U.K. authorities about an investigation in the United States.
[AP] - World stocks were mostly higher Thursday as news of a successful bond sale by Portugal eased worries over Europe's debt woes. But Chinese shares fell on fears that authorities might do more to cool the property sector.
[AP] - South Korea's central bank left its key interest rate near a record low Thursday for a second straight month as the risk of slowing global growth outweighed a buoyant outlook for the local economy.
[AP] - Korea National Oil Corp. says it won't raise its hostile takeover bid for Britain's Dana Petroleum. The statement released Thursday follows Dana's publication of a defense document which argued that the company was worth significantly more than KNOC's offer of 1.87 billion pounds , or 1,800 pence per share.
